Top Pharma Companies in India by Market Cap

BSE Sensex 74608.57 250.42 (-0.33%)

Filter

Top Pharma Companies in India as on Sep-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
1	Orchid Pharma Ltd.	Q V PT	5,923 Small Cap	1,125.20 (4.05%)	747.32	4.13	22.33	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Biocon Ltd.	Q V PT	62,743 Mid Cap	392 (-0.76%)	658.88	2.35	2.96	-18.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Healthcare Global Enterprises Ltd.	Q V+ PT	10,580 Small Cap	710.15 (1.35%)	626.07	6.5	17.43	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Indoco Remedies Ltd.	Q V+ PT	2,302 Small Cap	257.65 (0.33%)	421.02	2.37	8.25	-199.84	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Aster DM Quality Care Ltd.	Q V+ PT	65,885 Mid Cap	750.80 (-0.75%)	206.91	15.59	-11.61	19.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Cohance Lifesciences Ltd.	Q V+ PT	16,760 Small Cap	456.95 (-0.79%)	165.89	4.58	17.57	-18.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Dishman Carbogen Amcis Ltd.	Q V+ PT	2,672 Small Cap	170.90 (0.35%)	165.22	0.4	5.82	-33.01	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Tarsons Products Ltd.	Q V PT	1,631 Small Cap	331.20 (-2.59%)	163.05	2.86	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Krishna Institute of Medical Sciences Ltd	Q V PT	34,063 Small Cap	797.75 (1.04%)	162.31	8.76	24.04	3.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Sai Parenterals Ltd.	Q V PT	2,257 Small Cap	506.10 (-0.98%)	136.82	2.89	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Dr. Agarwals Health Care Ltd.	Q V PT	15,845 Small Cap	496.80 (1.43%)	104.66	7.51	34.58	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Laurus Labs Ltd.	Q V+ PT	1,05,645 Mid Cap	2,014.65 (-0.17%)	99.72	19.34	7.19	-2.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Rubicon Research Ltd.	Q V+ PT	29,031 Small Cap	1,704 (-1.58%)	99.43	21.35	41.00	54.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Nephrocare Health Services Ltd.	Q V+ PT	7,478 Small Cap	752.75 (0.17%)	98.35	6.66	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Sai Life Sciences Ltd.	Q V+ PT	34,003 Small Cap	1,606 (-0.11%)	94.41	13.38	23.61	39.96	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Gujarat Kidney And Super Speciality Ltd.	Q V PT	1,432 Small Cap	176 (-3.90%)	91.19	5.6	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Anthem Biosciences Ltd.	Q V PT	52,619 Mid Cap	905 (-1.46%)	89.86	16.54	14.00	16.46	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Wockhardt Ltd.	Q V+ PT	33,911 Small Cap	2,194.45 (0.31%)	86.91	7.06	4.49	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Torrent Pharmaceuticals Ltd.	Q V+ PT	1,82,738 Large Cap	4,954 (-0.28%)	86.64	21.05	11.80	13.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	Divis Laboratories Ltd.	Q V+ PT	2,48,664 Large Cap	9,366 (-0.70%)	85.6	14.18	8.67	4.44	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Vijaya Diagnostic Centre Ltd.	Q V+ PT	16,042 Small Cap	1,558 (0.01%)	85.58	15.93	16.66	14.99	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Apollo Hospitals Enterprise Ltd.	Q V+ PT	1,26,103 Large Cap	8,917.50 (-0.25%)	81.82	12.46	14.92	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Fischer Medical Ventures Ltd.	Q V PT	2,320 Small Cap	33.29 (1.28%)	77	4.93	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Global Health Ltd.	Q V PT	40,512 Small Cap	1,489.30 (-1.18%)	72.86	9.86	24.97	76.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	Acutaas Chemicals Ltd.	Q V+ PT	28,149 Small Cap	3,297.05 (-3.66%)	72.55	16.24	31.50	70.35	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	Max Healthcare Institute Ltd.	Q V PT	1,02,684 Mid Cap	1,068 (0.33%)	71.11	9.48	27.27	155.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Shilpa Medicare Ltd.	Q V+ PT	19,967 Small Cap	1,043.45 (-2.56%)	70.44	7.8	11.30	12.66	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	CORONA Remedies Ltd.	Q V+ PT	13,448 Small Cap	2,185.70 (-1.29%)	68.04	16.78	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Syngene International Ltd.	Q V+ PT	14,905 Small Cap	377.20 (-2.11%)	67.99	3.34	9.45	1.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	Viyash Scientific Ltd.	Q V PT	11,036 Small Cap	253.65 (0.73%)	64.97	3.95	20.23	2.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Anlon Healthcare	29.04	10%
Ind-Swift Labs.	408.25	7%
Shukra Pharmaceut.	58.90	6.63%
Aarti Pharmalabs	892.45	5.43%
Kilitch Drugs(India)	213.20	5%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Take	15.80	-4.13%
Guj. Kidney & Super	176	-3.90%
Acutaas Chemicals	3,297.05	-3.66%
Kopran	272.75	-3.64%
Kwality Pharma	3,702.80	-3.50%

News about Top Pharma Companies in India

Sep, 2026

Cohance Lifesciences informs about update

Cohance Lifesciences has informed that the United States Food and Drug Administration (USFDA) inspected the Company’s API manufacturing facility at Jaggaiahpet, Andhra Pradesh, India (FEI No. 3005554260), from 14 September to 19 September 2026. The inspection concluded with the issuance of a Form FDA 483 containing five observations. The Company has initiated appropriate corrective and preventive actions (CAPA) and will submit its response within the stipulated timeline. The Company remains committed to quality and regulatory compliance.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

USFDA concludes inspection at Cohance Lifesciences’ Andhra Pradesh facility

The inspection concluded with the issuance of a Form FDA 483 containing five observations

Sep, 2026

Biocon informs about press release

Biocon has informed that it enclosed the press release titled ‘Biocon’s Pertuzumab Becomes First Biosimilar to Secure EMA CHMP Approval Recommendation Under New Tailored Clinical Approach’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

HealthCare Global Enterprises informs about AGM

HealthCare Global Enterprises has informed that 28th Annual General Meeting (AGM) of the Members of the Company was held on Friday, September 18, 2026, at 5.00 pm (IST) through Video Conferencing (VC)/ Other Audio Visual Means (OAV) in compliance with the General Circulars issued by the Ministry of Corporate Affairs (MCA) and circulars issued by the Securities and Exchange Board of India (SEBI) and as per the applicable provisions of the Companies Act, 2013 and Listing Regulations. All the resolutions set out in the AGM notice have been approved by the Members with requisite majority. In this regard, they are enclosing the following: Consolidated report dated September 18, 2026, of the Scrutinizer signed by Mr. Pradeep B Kulkarni, Partner, V. Sreedharan & Associates, Company Secretaries, on e-voting and voting at the Annual General Meeting, in compliance with the provisions of Section 108 of the Companies Act, 2013 and Rule 20(4)(xii) of the Companies (Management and Administration) Rules 2014, annexed as Annexure-A and Voting results in compliance with Regulation 44(3) of the Listing Regulations read with SEBI Circular, annexed as Annexure- B.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

HealthCare Global Enterprises informs about scrutinizer’s report and voting results

HealthCare Global Enterprises has informed that 28th Annual General Meeting (AGM) of the Members of the Company was held on Friday, September 18, 2026, at 5.00 PM (IST) through Video Conferencing (‘VC’)/ Other Audio Visual Means (‘OAVM’) in compliance with the General Circulars issued by the Ministry of Corporate Affairs (‘MCA’) and circulars issued by the Securities and Exchange Board of India (‘SEBI’) and as per the applicable provisions of the Companies Act, 2013 and Listing Regulations. All the resolutions set out in the AGM notice have been approved by the Members with requisite majority. In this regard, it has enclosed the following: (i) Consolidated report dated September 18, 2026, of the Scrutinizer signed by Pradeep B Kulkarni, Partner, V. Sreedharan & Associates, Company Secretaries, on e-voting and voting at the Annual General Meeting, in compliance with the provisions of Section 108 of the Companies Act, 2013 and Rule 20(4)(xii) of the Companies (Management and Administration) Rules 2014, annexed as Annexure-A and (ii) Voting results in compliance with Regulation 44(3) of the Listing Regulations read with SEBI Circular, annexed as Annexure- B. The above information is also available on the website of the Company and can be accessed at: https://www.hcgoncology.com/.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Indoco Remedies gets nod to incorporate wholly owned subsidiary

The committee of executive directors of the company in its meeting held on September 18, 2026 has considered and approved the same

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Orchid Pharma Ltd.	5,923 Crore
2	Biocon Ltd.	62,743 Crore
3	Healthcare Global Enterprises Ltd.	10,580 Crore
4	Indoco Remedies Ltd.	2,302 Crore
5	Aster DM Quality Care Ltd.	65,885 Crore
6	Cohance Lifesciences Ltd.	16,760 Crore
7	Dishman Carbogen Amcis Ltd.	2,672 Crore
8	Tarsons Products Ltd.	1,631 Crore
9	Krishna Institute of Medical Sciences Ltd	34,063 Crore
10	Sai Parenterals Ltd.	2,257 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	27,196	57,954	35.89	11.20	24.65	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,954	1,82,738	83.79	20.36	38.34	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,451	67,169	37.36	6.13	12.46	27.89
Lupin Ltd. (M)	Somewhat Good	2,124	98,070	17.74	4.12	9.82	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,532	44,562	39.27	9.17	26.53	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,015	1,05,645	117
Sai Life Sciences Ltd. (S)	Somewhat Good	1,606	34,003	76.91
Aurobindo Pharma Ltd. (M)	Very Good	1,694	99,828	53.55
Divis Laboratories Ltd. (L)	Very Good	9,366	2,48,664	52.16
Gland Pharma Ltd. (M)	Very Good	2,912	48,875	45.50
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,606	34,003	94.00	13.32	48.48	23.61
Mankind Pharma Ltd. (M)	Very Good	2,461	95,744	46.87	5.69	24.40	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,532	44,562	39.27	9.17	26.53	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,168	1,15,012	25.48	4.27	14.28	13.52
Gland Pharma Ltd. (M)	Very Good	2,912	48,875	43.30	4.60	22.09	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,606	34,003	94.00	13.32	48.48	39.96
Lupin Ltd. (M)	Somewhat Good	2,124	98,070	17.74	4.12	9.82	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,451	67,169	37.36	6.13	12.46	22.19
Abbott India Ltd. (M)	Very Good	27,196	57,954	35.89	11.20	24.65	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,212	97,749	30.34	2.56	15.56	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Cohance Lifesciences informs about update

USFDA concludes inspection at Cohance Lifesciences’ Andhra Pradesh facility

Biocon informs about press release

HealthCare Global Enterprises informs about AGM

HealthCare Global Enterprises informs about scrutinizer’s report and voting results

Indoco Remedies gets nod to incorporate wholly owned subsidiary

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?